The AI landscape is buzzing with OpenAI's research team reorganization and new custom chip production with Broadcom, while **Anthropic faces a $1.5 billion copyright settlement for pirated data, and Warner Bros. sues Midjourney over AI-generated character knockoffs. Additionally, attorneys general issue warnings to OpenAI and Google Gemini is labeled high-risk for children, emphasizing the urgent need for AI safety and ethical guidelines**.

• OpenAI reorganizes research team behind ChatGPT’s personality — TechCrunch -
• Screw the money — Anthropic’s $1.5B copyright settlement sucks for writers — TechCrunch -
• “First of its kind” AI settlement: Anthropic to pay authors $1.5 billion — Ars Technica -

• Personalized AI companion app Dot is shutting down — TechCrunch -
• Attorneys general warn OpenAI ‘harm to children will not be tolerated’ — TechCrunch -
• Google Gemini dubbed ‘high risk’ for kids and teens in new safety assessment — TechCrunch -
• Warner Bros. sues Midjourney to stop AI knockoffs of Batman, Scooby-Doo — Ars Technica -
• Roblox announces short-form video feed for gameplay clips, new AI tools for creators, and more — TechCrunch -
• Warner Bros. sues Midjourney for AI images of Superman, Batman, and other characters — TechCrunch -
• ChatGPT’s new branching feature is a good reminder that AI chatbots aren’t people — Ars Technica -
• Scale AI’s former CTO launches AI agent that could solve big data’s biggest problem — TechCrunch -
• OpenAI hires the team behind Xcode coding assistant Alex — TechCrunch -
• Tesla shareholders to vote on investing in Musk’s AI startup xAI — TechCrunch -
• OpenAI links up with Broadcom to produce its own AI chips — Ars Technica -
• Snapchat’s new Lens lets you create AI images using text prompts — TechCrunch -
• Tesla proposes new pay package for Elon Musk worth up to $1T — TechCrunch -

The tech industry sees Apple preparing for its September event and Lenovo showcasing a swivel-screen laptop, while Google faces a 2.95 billion euro fine for adtech monopoly in Europe, and Firaxis Games announces layoffs despite positive projections for Civilization VII. Meanwhile, TechCrunch Disrupt 2025 promotional events are underway, and the US semiconductor market continues to evolve.

• What to expect (and not expect) from yet another September Apple event — Ars Technica -
• Civilization VII team at Firaxis Games faces layoffs — Ars Technica -
• Ignoring Trump threats, Europe hits Google with 2.95B euro fine for adtech monopoly — Ars Technica -

• Lenovo demos laptop with a screen you can swivel into portrait mode — Ars Technica -
• Cutting through the equity noise: Don’t miss this powerhouse panel at TechCrunch Disrupt 2025 — TechCrunch -
• A timeline of the US semiconductor market in 2025 — TechCrunch -
• Tesla’s ad spend on X has shrunk to almost nothing — TechCrunch -
• Natron’s liquidation shows why the US isn’t ready to make its own batteries — TechCrunch -
• X is now offering me end-to-end encrypted chat — you probably shouldn’t trust it yet — TechCrunch -
• Dev says Switch 2’s physical Game Cards were too slow for Star Wars Outlaws port — Ars Technica -
• The blueprint for lasting companies and communities with Discord’s Jason Citron and Campuswire’s Tade Oyerinde at TechCrunch Disrupt 2025 — TechCrunch -
• Today is your last chance to exhibit your brand in front of 10K tech leaders at TechCrunch Disrupt 2025 — TechCrunch -
• BMW debuts 6th-generation EV powertrain in the all-electric iX3 — Ars Technica -

In space news, NASA's acting chief expresses anger over suggestions that China could surpass the US in the Moon race, while the Neutron rocket's launchpad opens and SpaceX's Falcon 9 receives a green light for upcoming missions.

• NASA’s acting chief “angry” about talk that China will beat US back to the Moon — Ars Technica -
• Rocket Report: Neutron’s pad opens for business; SpaceX gets Falcon 9 green light — Ars Technica -

Public health continues to grapple with the complexities of COVID vaccine access, as the system remains a patchwork with many gray areas.

• Who can get a COVID vaccine—and how? It’s complicated. — Ars Technica -